Increased resting energy expenditure in subjects with Emery-Dreifuss muscular dystrophy

Neuromuscular Disorders

Volumn 14, Issue 2, 2004, Pages 142-146

  Vaisman, N ^a   Katzenellenbogen, S ^b   Nevo, Y ^b  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Emery Dreifuss muscular dystrophy; Lean body mass; Resting energy expenditure

Indexed keywords

CREATINE KINASE; CREATININE;

ADOLESCENT; ADULT; ARTICLE; BODY COMPOSITION; BODY FAT; CALORIC INTAKE; CALORIMETRY; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE URINE LEVEL; DUAL ENERGY X RAY ABSORPTIOMETRY; EMERY DREIFUSS MUSCULAR DYSTROPHY; ENERGY EXPENDITURE; ENZYME BLOOD LEVEL; HUMAN; LEAN BODY WEIGHT; MALE; MUSCLE FUNCTION; MUSCLE MASS; PRIORITY JOURNAL; REST;

EID: 0345829288     PISSN: 09608966     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nmd.2003.10.012     Document Type: Article

References (19)

1. Dubowitz V. Muscle disorders in childhood. 1995;Saunders, London.
2. Russell D.M., Leiter L.A., Whitwell J., Marliss E.B., Jeejeeboy K. Skeletal muscle function during hypocaloric diets and fasting: a comparison with standard nutritional assessment parameters. Am J Clin Nutr. 37:1983;133-138.
3. MaClave S.A., Snider H.L. Dissecting the energy needs of the body. Curr Opin Clin Nutr Metab Care. 4:2001;143-147.
4. Hankard R., Gottrand F., Truck D., Carpentier A., Romon M., Farriaux J.P. Resting energy expenditure and energy substrate utilization in children with Duchenne muscular dystrophy. Pediatr Res. 40:1996;29-33.
5. Satomura S., Yokota I., Tatara K., Naito E., Ito M., Kuroda Y. Paradoxical weight loss with extra energy expenditure at brown adipose tissue in adolescent patients with Duchenne muscular dystrophy. Metabolism. 50:2001;1181-1185.
6. Nevo Y., Ahituv S., Yaron Y., et al. Novel mutations in the emerin gene in Israeli families. Hum Mutat. 17:2001;522.
7. Ferrannini E. The theoretical bases of indirect calorimetry: a review. Metabolism. 37:1988;287-301.
8. Harris J.A., Benedict F.G. A biometric study of basal metabolism in man. vol. 279:1919;Carnegie Institute of Washington, Washington, DC.
9. Nelson K.M., Weinsier R.L., Long C.L., Schutz Y. Prediction of resting energy expenditure from fat-free mass and fat mass. Am J Clin Nutr. 56:1992;848-856.
10. Lukaski H.C. Methods for assessment of human body composition: traditional and new. Am J Clin Nutr. 46:1987;537-556.
11. Mokhatarian A., Decrouy A., Chunet A., Even P.C. Components of energy expenditure in the mdx mouse model of Duchenne muscular dystrophy. Plugers Arch. 43:1996;527-532.
12. Long C.L., Schaffel N., Geiger J.W., et al. Metabolic response to injury and illness: estimation of energy and protein needs from indirect calorimetry and nitrogen balance. J Parenteral Enteral Nutr. 3:1979;452-456.
13. Vaisman N., Rossi M., Pencharz P., Goldberg E. Changes in resting energy expenditure and substrate utilization during refeeding patients with anorexia nervosa. Eur J Clin Nutr. 45:1991;527-537.
14. Vaisman N., Clarke R., Pencharz P. Nutrition rehabilitation increases resting energy expenditure without affecting protein turnover in patients with cystic fibrosis. J Pediatr Gastroenterol Nutr. 13:1991;383-390.
15. Acheson K.J., Ravussin E., Schoeller D.A., et al. Two-week stimulation or blockade of sympathetic nervous system in man: influence on body weight, body composition and 24-hour energy expenditure. Metabolism. 37:1988;91-98.
16. Fontaine E.M., Keriel C., Lantuejoul S., Rigoulet M., Leverve X.M., Saks V.A. Cytoplasmic cellular structures control permeability of outer mitochondrial membrane for adp and oxidative phosphorilation in rat liver cells. Biochem Biophys Res Commun. 213:1995;138-146.
17. Griggs R.C., Forbes G., Moxley R.T., Herr B.E. The assessment of muscle mass in progressive neuromuscular disease. Neurology. 33:1983;158-165.
18. Shackleton S., Lloyd D.J., Jackson S.N., et al. LMNA, encoding lamin A/C, is mutated in partial lipodystrophy. Nat Genet. 24:2000;153-156.
19. Favreau C., Dubosclard E., Ostlund C., et al. Expression of Lamin A mutated in the carboxyl-terminal tail generates an aberrant nuclear phenotype similar to that observed in cells from patients with dunnigan-type partial lipodystrophy and Emery-Dreifuss muscular dystrophy. Exp Cell Res. 282:2003;14-23.